BBIO vs GMAB

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 24, 2026

BBIO

58.2
AI Score
VS
BBIO Wins

GMAB

40.6
AI Score

Investment Advisor Scores

BBIO

58score
Recommendation
HOLD

GMAB

41score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric BBIO GMAB Winner
Forward P/E 0 15.083 Tie
PEG Ratio 0 4.3581 Tie
Revenue Growth 120.4% 24.9% BBIO
Earnings Growth 0.0% -9.4% BBIO
Tradestie Score 58.2/100 40.6/100 BBIO
Profit Margin -97.0% 19.1% GMAB
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

BBIO 1M: +3.4% · 3M: -18.5% GMAB 1M: +25.7% · 3M: +52.0%

Current Technical Phase

BBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 52

RSI (14): 52.2 · Price: $68.56

GMAB

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (10.0% over 20 days), RSI 78

RSI (14): 78.0 · Price: $43.79

Fundamentals Snapshot

Metric BBIO GMAB
Market Cap — —
Forward P/E -305.3 28.9
Trailing P/E — 31.3
Revenue (TTM) — —
Revenue Growth 1.2% 0.2%
Gross Margin 0.9% 0.9%
Operating Margin -0.4% 0.4%
EPS -3.58 1.28
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, BBIO is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.